Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

​Biorithm is a medical technology company focused on advancing maternal and fetal care through digital health solutions. The company's flagship product, femom, is a remote monitoring platform that includes a clinical-grade fetal-maternal monitor, patient-reported symptom tracking, and connected point-of-care devices like blood pressure monitors and glucometers. The femom system enables clinicians to remotely assess the health of expectant mothers and their babies, facilitating early detection of complications and personalized care plans. Currently in the clinical investigation phase, femom aims to enhance continuity of care and empower patients and providers with data-driven insights. Visit website.

​Aqua Medical has developed a vapor-based, through-the-endoscope ablation technology aimed at treating gastrointestinal diseases and preventing gastrointestinal cancers. The RF Vapor Ablation (RFVA) System utilizes heated water vapor delivered via endoscopic catheters to ablate targeted tissue. The system is designed to be fluoroscopy-free and offers a range of catheters to address various conditions throughout the GI tract. Visit website.

The Atmo Gas Capsule is a unique ingestible capsule to provides unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, beginning with highly prevalent motility disorders such as gastroparesis and slow transit constipation. Visit website.

​Wellumio develops the Axana portable MRI system, designed to enable rapid stroke detection at the point of care. Unlike traditional MRI machines, Axana employs Pulsed Gradient Free Mapping (PGFM) technology, eliminating the need for bulky components and allowing for quick, bedside imaging. The device provides critical diagnostic information within minutes, facilitating timely treatment decisions during the crucial "golden hour" following a stroke. Wellumio is conducting clinical trials in Australia and has established a U.S. subsidiary to support regulatory filings and expand access to this technology. Visit website.

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

​Tensor Surgical develops the TransOs Tunneler System, an anchorless approach to rotator cuff repair and biceps tenodesis. This technique utilizes transosseous suturing to restore the native tendon-bone interface, aiming to enhance biological healing and reduce complications associated with suture anchors. The system is designed to simplify surgical workflows, reduce postoperative pain, and lower procedural costs. Tensor Surgical offers comprehensive training programs to support the adoption of this technique among orthopedic surgeons.​  Visit website.

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

NousQ is a Singapore-based company focused on developing patient-centric medical technologies. Its primary product, CLiKX, is a robotic, fully automated, and sensor-optimized handheld applicator designed for ventilation ear tube surgery. CLiKX aims to simplify the procedure by reducing the need for general anesthesia and the surgical microscope, allowing surgeries to be performed in outpatient settings. The device is designed to enhance precision and safety, potentially reducing costs and improving access to care for patients with otitis media effusion. Visit website.

Nevent develops tools to improve safety in vascular access procedures. Its primary product, the NEVENT Safety Sheath, is a patented device designed to prevent the unintended retention of guidewires during catheter-based interventions. Developed by an anesthesiologist, the sheath incorporates a capture mechanism that aims to reduce the risk of complications associated with retained guidewires. Nevent's mission is to engineer out human error in vascular access, thereby improving patient outcomes and operational efficiency in healthcare settings. Visit website.

InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

The Surgical-Fiberlcok technology functions like a surgical “sewing” machine, mechanically “interlocking” the medical patch fibers into soft tissue, allowing the surgeon to attach patches in an easier, faster, and more reliable way for various clinical applications for soft-tissue repair and augmentation. The enabling device for this technology, called FiberLocker® System, received FDA clearance for rotator cuff reinforcement in December 2024. Visit website.

​Vantis Vascular develops advanced tools for complex coronary and peripheral interventions. Its flagship product, the CrossFAST Integrated Microcatheter Advanced Delivery System, features DuoPro™ Interlocking Technology, coupling the microcatheter and outer catheter to enhance pushability and navigation. Designed for challenging anatomies, the system aims to improve procedural efficiency and safety. Currently available in the U.S. under a limited market release, a full launch is planned for 2025. Visit website.

LearUp is a cloud-based workflow automation platform designed for small and mid-sized life sciences companies. The platform streamlines project management by integrating tools for remote team collaboration, milestone tracking, and budget oversight. LearUp's solution aims to enhance operational efficiency and support digital execution across various organizational functions. Visit website.

Onera Health is advancing sleep diagnostics through its patch-based technology designed for clinical and at-home use. The company’s solutions provide comprehensive sleep data to physicians, helping optimize care for patients with sleep-related conditions. By enabling more accessible and efficient testing, Onera supports improved outcomes while reducing overall healthcare costs. Visit website.

Lemonex is a clinical-stage biotechnology company developing thermostable RNA vaccines and gene therapeutics using its proprietary DegradaBALL® drug delivery system. DegradaBALL® is a non-viral, porous nanoparticle platform that enables room-temperature storage and reduces systemic side effects compared to conventional lipid nanoparticles. The company is partnered with CEPI to support pandemic preparedness through improved mRNA delivery. Lemonex’s technology aims to broaden global access to RNA medicines by improving stability, safety, and ease of administration.   Visit website.

LiveMetric develops a wrist-worn wearable device for continuous, calibration-free blood pressure monitoring. The FDA- and CE-cleared system captures arterial pressure waveforms at 100Hz, enabling real-time insights into cardiac output, heart rate, and stroke volume. Designed for remote monitoring and long-term cardiovascular care, the device provides ICU-level data without the need for traditional cuffs. LiveMetric supports scalable access to heart health information for patients, providers, and healthcare systems. Visit website.

Calla Lily Clinical Care is a women’s health-focused company pioneering the proprietary Callavid® platform for intravaginal drug delivery. Its first application targets IVF treatments, and will also position Callavid® as the world’s first drug–device combination product specifically aimed at miscarriage prevention.  Future indications include gynecological cancers and the delivery of live biotherapeutic products (LBPs) to reduce reliance on antibiotics and help combat antimicrobial resistance (AMR).  Calla Lily is redefining drug delivery in women’s health with precision, patient comfort, and global impact in mind.  Visit website.

Medulla Pro develops technology to support guided needle insertion procedures, with the goal of improving accuracy and reducing complications. The company’s solutions are designed for use in lumbar puncture and nerve block procedures, offering enhanced precision for clinicians and better outcomes for patients. Medulla Pro is focused on making guided procedures the standard of care through the application of advanced engineering. Visit website.

Neurosom™ is developing medical devices that integrate real-time sleep assessment with personalized therapy to support restorative health. The company’s Sleep WISP system is a wearable headband that uses EEG and machine learning to monitor sleep cycles and apply painless electrical stimulation to promote sleep onset and enhance deep sleep. Designed for home use, the system enables users to engage in sleep therapy without clinical oversight. Neurosom™ aims to advance the field of sleep through non-invasive, technology-driven solutions. Visit website.

Haventure is a Medtech startup cluster founded by Stéphane Lavallée, bringing together a diverse portfolio of innovative companies with a strong foundation in digital surgery and robotics:    Notable startups within the cluster include: Spinem Robotics, developing a next-generation robotic and navigation platform for spine surgery. Extremis Robotics, focused on robotic and navigation solutions for foot and ankle surgery. Kyniska Robotics, creating the first robotic platform dedicated to sports medicine procedures. Haventure also supports a groundbreaking venture in women's health : Matria Health Technology, which is developing an innovative device to treat postpartum hemorrhage. Visit website.

Accure Medical is revolutionizing dermatology with the Accure Laser System, the first 1726nm platform to achieve both CE Mark certification and FDA clearance for the long-term treatment of mild to severe inflammatory acne vulgaris. Leveraging its patented treat-to-temperature technology, the system ensures consistent, safe, and effective results for all skin types. With rapid adoption across the US, Europe, Asia, and the Middle East, Accure is addressing a significant global need with its groundbreaking solution for acne treatment. Visit website.

VeinTech is an Australian medical technology company developing solutions to improve the accuracy and efficiency of intravenous (IV) cannulation. The company’s VeinWise System uses patented ultrasound-based technology to visualize vein pathways at depth, addressing long-standing limitations of the traditional landmark technique. Designed for ease of use and portability, the system supports clinicians in reducing insertion failures while enhancing patient comfort and clinical workflow. VeinTech’s approach aims to improve outcomes across healthcare settings by reducing complications and associated costs. Visit website.